February 2025 Price Concessions 3rd Update

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (27/02/2025) announced the following list of price concessions for February 2025:

Please note: Following a mid-month price increase reported by pharmacy owners, Community Pharmacy England has secured an upward price adjustment for the product listed in the table below.

  • Prucalopride 2mg tablets

This is not the final update for February. We are still working with the DHSC to agree concessionary prices for other drugs reported to be unavailable at the stated February 2025 Drug Tariff prices. Please note: We are unable to provide details of any generic products awaiting price concession approval from DHSC.

Drug Pack size Price concession
Buprenorphine 8mg sublingual tablets sugar free 7 £4.98
Calcium and Ergocalciferol tablets 28 £6.82
Captopril 25mg tablets 56 £22.45
Clotrimazole 500mg pessary and Clotrimazole 2% cream 1 £6.30
Codeine 15mg/5ml linctus 200 £16.50
Diclofenac potassium 50mg tablets 28 £7.41
Lidocaine 2% cream 30 £3.81
Memantine 20mg tablets 28 £3.69
Mometasone 0.1% cream 30 £3.59
Oxybutynin 5mg tablets 56 £3.50
Propantheline bromide 15mg tablets 112 £103.33
Prucalopride 2mg tablets 28 £10.94 (previously £10.00)
Riluzole 50mg tablets 56 £361.07

For the full list of price concessions granted for February 2025 so far please visit our price concession hub page here.

No additional endorsements are required for price concessions. A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.

We encourage pharmacies to report any problems obtaining a Part VIII product at or below the stated Drug Tariff price, using the online feedback form on the Community Pharmacy England website. Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. We will investigate the extent of the problem and, if appropriate, discuss the issue with DHSC.

Please  subscribe to our mailing list to receive email updates of any price concessions.

Further information on price  concessions and FAQs about the process  involved  can be found on our website (cpe.org.uk/priceconcessions) Please see our latest funding and reimbursement short videos for further information on the recent changes to the price concession process.

CLOSING SOON: Share your experiences today to contribute directly to the ongoing work to deliver a stronger future for community pharmacy.

Click Here